[1] |
de Ligt J, Willemsen MH, van Bon BW, et al. Diagnostic exome sequencing in persons with severe intellectual disability[J]. N Engl J Med, 2012, 367(20): 1921-1929.
doi: 10.1056/NEJMoa1206524
|
[2] |
Kuechler A, Willemsen MH, Albrecht B, et al. De novo mutations in beta-catenin (CTNNB1) appear to be a frequent cause of intellectual disability: expanding the mutational and clinical spectrum[J]. Hum Genet, 2015, 134(1): 97-109.
doi: 10.1007/s00439-014-1498-1
pmid: 25326669
|
[3] |
Ke Z, Chen Y. Case report: a de novo CTNNB1 nonsense mutation associated with neurodevelopmental disorder, retinal detachment, polydactyly[J]. Front Pediatr, 2020, 8: 575673.
doi: 10.3389/fped.2020.575673
|
[4] |
Verhoeven WMA, Egger JIM, Jongbloed RE, et al. A de novo CTNNB1 novel splice variant in an adult female with severe intellectual disability[J]. Int Med Case Rep J, 2020, 13: 487-492.
|
[5] |
Winczewska-Wiktor A, Badura-Stronka M, Monies-Nowicka A, et al. A de novo CTNNB1 nonsense mutation associated with syndromic atypical hyperekplexia, microcephaly and intellectual disability: a case report[J]. BMC Neurol, 2016, 16: 35.
doi: 10.1186/s12883-016-0554-y
pmid: 26968164
|
[6] |
Kharbanda M, Pilz DT, Tomkins S, et al. Clinical features associated with CTNNB1 de novo loss of function mutations in ten individuals[J]. Eur J Med Genet, 2017, 60(2): 130-135.
doi: S1769-7212(16)30249-X
pmid: 27915094
|
[7] |
Takezawa Y, Kikuchi A, Haginoya K, et al. Genomic analysis identifies masqueraders of full-term cerebral palsy[J]. Ann Clin Transl Neurol, 2018, 5(5): 538-551.
doi: 10.1002/acn3.551
|
[8] |
Yan R, Liu P, Li F, et al. Generation of a human induced pluripotent stem cell line (SBWCHi001-A) from a patient with NEDSDV carrying a pathogenic mutation in CTNNB1 gene[J]. Stem Cell Res, 2020, 49: 102091.
doi: 10.1016/j.scr.2020.102091
|
[9] |
Wang H, Zhao Y, Yang L, et al. Identification of a novel splice mutation in CTNNB1 gene in a Chinese family with both severe intellectual disability and serious visual defects[J]. Neurol Sci, 2019, 40(8): 1701-1704.
doi: 10.1007/s10072-019-03823-5
pmid: 30929091
|
[10] |
Li N, Xu Y, Li G, et al. Exome sequencing identifies a de novo mutation of CTNNB1 gene in a patient mainly presented with retinal detachment, lens and vitreous opacities, microcephaly, and developmental delay: case report and literature review[J]. Medicine (Baltimore), 2017, 96(20): e6914.
doi: 10.1097/MD.0000000000006914
|
[11] |
Jin SC, Lewis SA, Bakhtiari S, et al. Mutations disrupting neuritogenesis genes confer risk for cerebral palsy[J]. Nat Genet, 2020, 52(10): 1046-1056.
doi: 10.1038/s41588-020-0695-1
|
[12] |
Dixon MW, Stem MS, Schuette JL, et al. CTNNB1 mutation associated with familial exudative vitreoretinopathy (FEVR) phenotype[J]. Ophthalmic Genet, 2016, 37(4): 468-470.
doi: 10.3109/13816810.2015.1120318
|
[13] |
Coussa RG, Zhao Y, DeBenedictis MJ, et al. Novel mutation in CTNNB1 causes familial exudative vitreoretinopathy (FEVR) and microcephaly: case report and review of the literature[J]. Ophthalmic Genet, 2020, 41(1): 63-68.
doi: 10.1080/13816810.2020.1723118
|
[14] |
Panagiotou ES, Sanjurjo Soriano C, Poulter JA, et al. Defects in the Cell Signaling Mediator beta-Catenin Cause the Retinal Vascular Condition FEVR[J]. Am J Hum Genet, 2017, 100(6): 960-968.
doi: S0002-9297(17)30188-X
pmid: 28575650
|
[15] |
Zhu X, Yang M, Zhao P, et al. Catenin alpha 1 mutations cause familial exudative vitreoretinopathy by overactivating Norrin/beta-catenin signaling[J]. J Clin Invest, 2021, 131(6): e139869.
doi: 10.1172/JCI139869
|
[16] |
Sun W, Xiao X, Li S, et al. Germline mutations in CTNNB1 associated with syndromic FEVR or norrie disease[J]. Invest Ophthalmol Vis Sci, 2019, 60(1): 93-97.
doi: 10.1167/iovs.18-25142
|
[17] |
Dong F, Jiang J, McSweeney C, et al. Deletion of CTNNB1 in inhibitory circuitry contributes to autism-associated behavioral defects[J]. Hum Mol Genet, 2016, 25(13): 2738-2751.
|
[18] |
Tucci V, Kleefstra T, Hardy A, et al. Dominant beta-catenin mutations cause intellectual disability with recognizable syndromic features[J]. J Clin Invest, 2014, 124(4): 1468-1482.
doi: 10.1172/JCI70372
|
[19] |
Brault V, Moore R, Kutsch S, et al. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development[J]. Development, 2001, 128(8): 1253-1264.
doi: 10.1242/dev.128.8.1253
pmid: 11262227
|